著者検索結果

1

New biologics and small molecules in inflammatory bowel disease: an update 著者: João Sabino, Bram Verstockt, Séverine Vermeire, Marc Ferrante

出版事項 2019

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
2

Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD 著者: Martina Poletti, Kaline Arnauts, Marc Ferrante, Tamás Korcsmáros

出版事項 2020

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
3

New treatment options for inflammatory bowel diseases 著者: Bram Verstockt, Marc Ferrante, Séverine Vermeire, Gert Van Assche

出版事項 2018

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
4

Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy? 著者: Amelie Decock, Gert Van Assche, Séverine Vermeire, Wim Wuyts, Marc Ferrante

出版事項 2016

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
5

Therapeutic Drug Monitoring During Induction of Anti–Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease 著者: Konstantinos Papamichael, Niels Vande Casteele, Marc Ferrante, Ann Gils, Adam S. Cheifetz

出版事項 2017

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
6

Predictive Model for the Outcome of Infliximab Therapy in Crohnʼs Disease Based on Apoptotic Pharmacogenetic Index and Clinical Predictors 著者: Tibor Hlavatý, Marc Ferrante, Liesbet Henckaerts, Rajaraman Eri, Paul Rutgeerts, Séverine Vermeire

出版事項 2006

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
7

Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease 著者: Liesbet Henckaerts, Marieke Pierik, Marie Joossens, Marc Ferrante, P. Rutgeerts, Séverine Vermeire

出版事項 2007

全文の入手
Artigo

お気に入りに追加

保存先:
8

Tofacitinib concentrations in plasma and breastmilk of a lactating woman with ulcerative colitis 著者: Mette Julsgaard, Uma Mahadevan, Thea Vestergaard, Raf Mols, Marc Ferrante, Patrick Augustijns

出版事項 2023

全文の入手
Carta

お気に入りに追加

保存先:
9

Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease 著者: Triana Lobatón, Marc Ferrante, P. Rutgeerts, Vera Ballet, Gert Van Assche, Séverine Vermeire

出版事項 2015

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
10

Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs? 著者: Wannee Kantasiripitak, Ruth Van Daele, Matthias Gijsen, Marc Ferrante, Isabel Spriet, Erwin Dreesen

出版事項 2020

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
11

Ex Vivo Mimicking of Inflammation in Organoids Derived From Patients With Ulcerative Colitis 著者: Kaline Arnauts, Bram Verstockt, Anabela S. Ramalho, Séverine Vermeire, Catherine M. Verfaillie, Marc Ferrante

出版事項 2020

全文の入手
Artigo

お気に入りに追加

保存先:
12

Update on the Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding 著者: Sophie Restellini, Luc Biedermann, Petr Hrúz, Christian Mottet, Annick Moens, Marc Ferrante, Alain Schoepfer

出版事項 2020

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
13

Understanding the Molecular Drivers of Disease Heterogeneity in Crohn’s Disease Using Multi-omic Data Integration and Network Analysis 著者: Padhmanand Sudhakar, Bram Verstockt, Jonathan Cremer, Sare Verstockt, João Sabino, Marc Ferrante, Séverine Vermeire

出版事項 2020

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
14

Prognostic factors for long‐term infliximab treatment in Crohn's disease patients: a 20‐year single centre experience 著者: Thomas Billiet, Isabelle Cleynen, Vera Ballet, Marc Ferrante, Gert Van Assche, Ann Gils, Séverine Vermeire

出版事項 2016

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
15

Incidence of Colectomy During Long-term Follow-up After Cyclosporine-Induced Remission of Severe Ulcerative Colitis 著者: David N. Moskovitz, Gert Van Assche, Benedikte Maenhout, Joris Arts, Marc Ferrante, Séverine Vermeire, Paul Rutgeerts

出版事項 2006

全文の入手
Artigo

お気に入りに追加

保存先:
16

Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease 著者: Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Gert Van Assche, Marc Ferrante, Ann Gils, Séverine Vermeire

出版事項 2018

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
17

Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease 著者: Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Gert Van Assche, Marc Ferrante, Ann Gils, Séverine Vermeire

出版事項 2019

全文の入手
Artigo

お気に入りに追加

保存先:
18

DOP22 Integrative -omic analysis reveals microbiota mediated molecular mechanisms influencing host mucosal gene expression in Crohn’s Disease 著者: Padhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, Clara Caenepeel, Marc Ferrante, João Sabino, Bram Verstockt, Séverine Vermeire

出版事項 2021

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
19

Integrated analysis of microbe-host interactions in Crohn’s disease reveals potential mechanisms of microbial proteins on host gene expression 著者: Padhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, Clara Caenepeel, Marc Ferrante, João Sabino, Bram Verstockt, Séverine Vermeire

出版事項 2022

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
20

Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis 著者: Konstantinos Papamichael, Filip Baert, Sophie Tops, Gert Van Assche, Paul Rutgeerts, Séverine Vermeire, Ann Gils, Marc Ferrante

出版事項 2016

全文の入手
Artigo

お気に入りに追加

保存先:

検索結果 - Marc Ferrante

New biologics and small molecules in inflammatory bowel disease: an update 著者: João Sabino, Bram Verstockt, Séverine Vermeire, Marc Ferrante

Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD 著者: Martina Poletti, Kaline Arnauts, Marc Ferrante, Tamás Korcsmáros

New treatment options for inflammatory bowel diseases 著者: Bram Verstockt, Marc Ferrante, Séverine Vermeire, Gert Van Assche

Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy? 著者: Amelie Decock, Gert Van Assche, Séverine Vermeire, Wim Wuyts, Marc Ferrante

Therapeutic Drug Monitoring During Induction of Anti–Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease 著者: Konstantinos Papamichael, Niels Vande Casteele, Marc Ferrante, Ann Gils, Adam S. Cheifetz

Predictive Model for the Outcome of Infliximab Therapy in Crohnʼs Disease Based on Apoptotic Pharmacogenetic Index and Clinical Predictors 著者: Tibor Hlavatý, Marc Ferrante, Liesbet Henckaerts, Rajaraman Eri, Paul Rutgeerts, Séverine Vermeire

Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease 著者: Liesbet Henckaerts, Marieke Pierik, Marie Joossens, Marc Ferrante, P. Rutgeerts, Séverine Vermeire

Tofacitinib concentrations in plasma and breastmilk of a lactating woman with ulcerative colitis 著者: Mette Julsgaard, Uma Mahadevan, Thea Vestergaard, Raf Mols, Marc Ferrante, Patrick Augustijns

Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease 著者: Triana Lobatón, Marc Ferrante, P. Rutgeerts, Vera Ballet, Gert Van Assche, Séverine Vermeire

Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs? 著者: Wannee Kantasiripitak, Ruth Van Daele, Matthias Gijsen, Marc Ferrante, Isabel Spriet, Erwin Dreesen

Ex Vivo Mimicking of Inflammation in Organoids Derived From Patients With Ulcerative Colitis 著者: Kaline Arnauts, Bram Verstockt, Anabela S. Ramalho, Séverine Vermeire, Catherine M. Verfaillie, Marc Ferrante

Update on the Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding 著者: Sophie Restellini, Luc Biedermann, Petr Hrúz, Christian Mottet, Annick Moens, Marc Ferrante, Alain Schoepfer

Understanding the Molecular Drivers of Disease Heterogeneity in Crohn’s Disease Using Multi-omic Data Integration and Network Analysis 著者: Padhmanand Sudhakar, Bram Verstockt, Jonathan Cremer, Sare Verstockt, João Sabino, Marc Ferrante, Séverine Vermeire

Prognostic factors for long‐term infliximab treatment in Crohn's disease patients: a 20‐year single centre experience 著者: Thomas Billiet, Isabelle Cleynen, Vera Ballet, Marc Ferrante, Gert Van Assche, Ann Gils, Séverine Vermeire

Incidence of Colectomy During Long-term Follow-up After Cyclosporine-Induced Remission of Severe Ulcerative Colitis 著者: David N. Moskovitz, Gert Van Assche, Benedikte Maenhout, Joris Arts, Marc Ferrante, Séverine Vermeire, Paul Rutgeerts

Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease 著者: Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Gert Van Assche, Marc Ferrante, Ann Gils, Séverine Vermeire

Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease 著者: Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Gert Van Assche, Marc Ferrante, Ann Gils, Séverine Vermeire

DOP22 Integrative -omic analysis reveals microbiota mediated molecular mechanisms influencing host mucosal gene expression in Crohn’s Disease 著者: Padhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, Clara Caenepeel, Marc Ferrante, João Sabino, Bram Verstockt, Séverine Vermeire

Integrated analysis of microbe-host interactions in Crohn’s disease reveals potential mechanisms of microbial proteins on host gene expression 著者: Padhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, Clara Caenepeel, Marc Ferrante, João Sabino, Bram Verstockt, Séverine Vermeire

Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis 著者: Konstantinos Papamichael, Filip Baert, Sophie Tops, Gert Van Assche, Paul Rutgeerts, Séverine Vermeire, Ann Gils, Marc Ferrante

検索ツール:

関連主題